fda semaglutide warning news october 2025 National Hispanic Medical Association | After compounded GLP-1 drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and FDA says Ozempic, Wegovy are
Description
AS CONSIDERATION FOR USER'S OPPORTUNITY TO USE THE GENERAL INFORMATION AND PROCESSES PROVIDED ON THIS SITE, USER AGREES THAT UNDER NO CIRCUMSTANCES WHATSOEVER WILL MTA OR ANYONE ASSOCIATED WITH MTA OR THIS SITE BE LIABLE IN ANY WAY TO YOU OR ANY OTHER ENTITY FOR ANY ACTION OR INACTION TAKEN BY USER IN RELIANCE UPON INFORMATION OR SERVICES PROVIDED THROUGH THIS SITE
McAfee warns that overly rosy promises of results are a sign of a scam
They created 3 matched cohorts: Cohort 1: Patients with obesity (without diabetes) GLP-1 users were compared with non-users (1,610 patients/group)
With physician supervised semaglutide treatment in New Hampshire, patients receive personalized care
